Skin Laboratory Public Company Limited
0.82
THB
0.00
(0.00%)
ISIN
THD134010004
Return %
Stock
S&P 500
1Y
-53.14
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
THB
•
in mil. unless spec.Working Capital
THB
•
in mil. unless spec.Growth Rates
THB
•
in mil. unless spec.Quarterly Revenue
THB
•
in mil. unless spec.Quarterly Earnings Per Share
THB
•
in mil. unless spec.Quarterly Dividends Per Share
THB
•
in mil. unless spec.Company Description
- CEO
- Chanwit Khieonawawongsa
- Full Time Employees
- 30
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Address
- Nonthaburi Thailand
- IPO Date
- Sep 24, 2025
- Website
- skinsista.com
- Similar Companies
- Business
- Skin Laboratory Public Company Limited is a Thailand-based original equipment manufacturer (OEM) and original design manufacturer (ODM) engaged in the research, development, formulation, and contract manufacturing of skincare, cosmetics, personal care, and dietary supplement products. Founded in 2014 and headquartered in Bangkok, Thailand, the company provides end-to-end turnkey private-label production services catering to beauty brand owners, dermatological clinics, retail enterprises, and direct-to-consumer wellness brands across domestic and international markets, primarily within the Southeast Asian region. The company offers a comprehensive range of contract manufacturing services and product formulations organized across core categories: facial skincare products, including anti-aging creams, brightening serums, hydrating essences, acne treatments, facial cleansers, toners, and broad-spectrum sunscreens; body and personal care formulations, encompassing moisturizing lotions, exfoliating scrubs, shower gels, hand creams, and body mists; hair and scalp care treatments, comprising specialized shampoos, conditioners, scalp revitalizing tonics, and hair serums; color cosmetics, such as liquid foundations, BB and CC creams, lip tints, and tinted sunscreens; dietary supplements and nutricosmetics, featuring collagen beverages, antioxidant powders, vitamin capsules, herbal health formulations, and weight management products; and end-to-end private-label support services, including customized formulation research and development, active ingredient sourcing, packaging design, microbiological quality control, stability testing, and regulatory registration compliance with the Food and Drug Administration (FDA) and international trade standards. In recent strategic developments, Skin Laboratory Public Company Limited has implemented several operational and commercial initiatives to scale production capacity and enhance technological capabilities. Over the past two years, the company completed modernization programs across its manufacturing facilities, integrating automated cleanroom production lines and high-speed filling systems compliant with ISO 22716, Good Manufacturing Practice (GMP), and Halal certification standards. The company expanded its specialized research and development laboratory to focus on high-performance bioactive ingredients, including plant-derived stem cell extracts, microbiome-balancing complexes, and peptide delivery systems. To address growing market demand in the preventive health and functional nutrition sectors, the company enlarged its dietary supplement manufacturing unit, introducing modern delivery formats such as single-serve liquid pouches, effervescent tablets, and micro-encapsulated powders. Additionally, Skin Laboratory Public Company Limited established cross-border supply partnerships to expand its contract manufacturing footprint into emerging Southeast Asian markets while introducing sustainable packaging alternatives, including post-consumer recycled plastics and biodegradable packaging components.